Prediction Abilities of SCORE2 Risk Algorithms for Incident Dementia and All-Cause Mortality: Results From the UK Biobank Cohort Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Whether the updated Systematic COronary Risk Evaluation (SCORE2) risk algorithm is suitable for the prediction of incident dementia and all-cause mortality and whether its discrimination abilities for these outcomes are higher than those of the SCORE and Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) risk algorithms are unclear. Methods: The present study included 429 033 participants (mean age: 57.1 ± 8.1 years; male: 46.2%; White: 94.1%) free of dementia from the UK Biobank at baseline, with a median follow-up of 12.8 years. Cox regression models were adopted to investigate the longitudinal relationships of SCORE2 risk categories with outcomes, and receiver operating characteristic curve analyses were used to compare the discrimination abilities of the 3 algorithms. Results: During 5 376 778 person-years of follow-up, 6 477 all-cause dementia, 2 726 Alzheimer’s disease (AD), 1 439 vascular disease (VD), and 31 981 all-cause deaths were identified. We found that higher SCORE2 risk was associated with higher risks of all-cause dementia, AD, VD, and all-cause mortality. The C-indices of SCORE2 risk for discriminating incident all-cause dementia, AD, VD, and all-cause death were 0.750 (95% confidence interval [CI]: 0.745 to 0.755), 0.750 (95% CI: 0.743 to 0.757), 0.800 (95% CI: 0.791 to 0.809), and 0.721 (95% CI: 0.718 to 0.724), respectively, which were significantly improved in comparison to those of the SCORE and CAIDE risk algorithms. Conclusion: The SCORE2 risk algorithm is applicable in predicting incident all-cause dementia, AD, VD, and all-cause mortality in European populations, and its discrimination abilities for dementia and death are significantly higher than those of the SCORE and CAIDE risk algorithms. Further validations in other populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCORE2 working group and ESC Cardiovascular risk collaboration, Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab309 · Cited by 1,810
Gottesman, R. F., Albert, M. S., Alonso, A., Coker, L. H., Coresh, J., Davis, S. M., Deal, J. A., McKhann, G. M., Mosley, T. H., Sharrett, A. R., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1658 · Cited by 633
Ott, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535
Ou, Y.-N., Tan, C.-C., Shen, X.-N., Xu, W., Hou, X.-H., Dong, Q., Tan, L., & Yu, J.-T. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14993 · Cited by 402
HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W. (2018) · Diabetologia · doi:10.1007/s00125-017-4541-7 · Cited by 280
Self-citationIwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00150-1 · Cited by 161
Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W. (2021) · BMC Medicine · doi:10.1186/s12916-021-02165-4 · Cited by 64
Self-citation
Research works printed but not linked: 20
- GBD Dementia Collaborators, 2019, Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol., 18, 88, 10.1016/S1474-4422(18)30403-4 · DOI · Paper page
- Debette, 2011, Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline, Neurology., 77, 461, 10.1212/WNL.0b013e318227b227 · DOI · Paper page
- Kivipelto, 2006, Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study, Lancet Neurol., 5, 735, 10.1016/S1474-4422(06)70537-3 · DOI · Paper page
- Song, 2021, Association of cardiovascular risk burden with risk of dementia and brain pathologies: a population-based cohort study, Alzheimers Dement., 17, 1914, 10.1002/alz.12343 · DOI
- Hewitt, 2016, Cohort profile of the UK Biobank: diagnosis and characteristics of cerebrovascular disease, BMJ Open, 6, e009161, 10.1136/bmjopen-2015-009161 · DOI · Paper page
- SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration, 2021, SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions, Eur Heart J., 42, 2455, 10.1093/eurheartj/ehab312 · DOI · Paper page
- Bhatnagar, 2016, Trends in the epidemiology of cardiovascular disease in the UK, Heart, 102, 1945, 10.1136/heartjnl-2016-309573 · DOI · Paper page
- Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J., 24, 987, 10.1016/S0195-668X(03)00114-3 · DOI · Paper page
- Visseren, 2021, 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, Eur Heart J., 42, 3227, 10.1093/eurheartj/ehab484 · DOI · Paper page
- Reitz, 2005, Effect of smoking and time on cognitive function in the elderly without dementia, Neurology, 65, 870, 10.1212/01.wnl.0000176057.22827.b7 · DOI · Paper page
- Li, 2022, Association of cumulative blood pressure with cognitive decline, dementia, and mortality, J Am Coll Cardiol, 79, 1321, 10.1016/j.jacc.2022.01.045 · DOI · Paper page
- Li, 2021, Dose–response relationship between long-term blood pressure variability and cognitive decline, Stroke, 52, 3249, 10.1161/STROKEAHA.120.033697 · DOI
- Elias, 2005, Serum cholesterol and cognitive performance in the Framingham Heart Study, Psychosom Med., 67, 24, 10.1097/01.psy.0000151745.67285.c2 · DOI · Paper page
- Singh-Manoux, 2008, Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study, Arterioscler Thromb Vasc Biol, 28, 1556, 10.1161/ATVBAHA.108.163998 · DOI · Paper page
- Hua, 2021, Low levels of low-density lipoprotein cholesterol and cognitive decline, Sci Bull, 66, 1684, 10.1016/j.scib.2021.02.018 · DOI · Paper page
- Exalto, 2014, Midlife risk score for the prediction of dementia four decades later, Alzheimers Dement, 10, 562, 10.1016/j.jalz.2013.05.1772 · DOI · Paper page
- Li, 2018, Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study, Alzheimers Dement, 14, 35, 10.1016/j.jalz.2017.04.013 · DOI
- Kaffashian, 2013, Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores, Neurology, 80, 1300, 10.1212/WNL.0b013e31828ab370 · DOI · Paper page
- Zheng, 2019, Progression of cognitive decline before and after incident stroke, Neurology, 93, e20, 10.1212/WNL.0000000000007716 · DOI
- Xie, 2019, Cognitive decline before and after incident coronary events, J Am Coll Cardiol, 73, 3041, 10.1016/j.jacc.2019.04.019 · DOI · Paper page
Metadata
- Authors
- Zheng, F., Xie, W., Li, C., Gao, D., & Liang, J.
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-12-13
- Volume
- 78
- Issue
- 4
- Pages
- 704-710
- ISSN
- 1079-5006
- 1758-535X
- Cited by
- 12
- References
- 7
- Language
- en
- Funders
- National Natural Science Foundation of China (81974490)
- Nonprofit Central Research Institute
- Chinese Academy of Medical Sciences (2021-RC330-001)
- Health Research Project
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.